Nyxoah is trading 5.7% down at $1.33 after its August 5, 2026 earnings release delivered strong revenue growth but continued heavy losses.

  • Q2 revenue reached €7.7 million, while operating loss remained €20.6 million.
  • SG&A increased as the U.S. commercial organization expanded.
  • Management maintained 2026 revenue guidance of €36 million–€40 million; the reaction is negative despite robust U.S. launch momentum.